OTCMKTS:VBIO - Vitality Biopharma Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.58 -0.01 (-1.69 %) (As of 01/22/2019 01:13 AM ET)Previous Close$0.59Today's Range$0.50 - $0.6052-Week Range$0.04 - $2.33Volume3,817 shsAverage Volume30,183 shsMarket Capitalization$19.84 millionP/E RatioN/ADividend YieldN/ABeta1.7 ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States. The company's products in pipeline include VBX-100, an oral cannabinoid formulation for inflammatory bowel disease, C.difficile-associated diarrhea and colitis, and narcotic bowel syndrome; and VBX-210, a cannabinoid formulation, which is in preclinical studies for the treatment of gastrointestinal conditions. It develops additional cannabinoid product formulations for refractory pain and autism spectrum disorder. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. The company was founded in 2007 and is based in Los Angeles, California. Receive VBIO News and Ratings via Email Sign-up to receive the latest news and ratings for VBIO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:VBIO Previous SymbolOTCMKTS:STVF CUSIPN/A Webwww.vitality.bio Phone530-231-7800Debt Debt-to-Equity RatioN/A Current Ratio0.46 Quick Ratio0.46Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$100,000.00 Price / Sales198.36 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book58.00Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-4,300,000.00 Net Margins-4,355.14% Return on Equity-3,389.09% Return on Assets-719.69%Miscellaneous Employees7 Outstanding Shares34,200,000Market Cap$19.84 million OptionableNot Optionable Vitality Biopharma (OTCMKTS:VBIO) Frequently Asked Questions What is Vitality Biopharma's stock symbol? Vitality Biopharma trades on the OTCMKTS under the ticker symbol "VBIO." How were Vitality Biopharma's earnings last quarter? Vitality Biopharma Inc (OTCMKTS:VBIO) issued its quarterly earnings results on Wednesday, November, 14th. The company reported ($0.05) EPS for the quarter. The firm earned $0.04 million during the quarter. Vitality Biopharma had a negative net margin of 4,355.14% and a negative return on equity of 3,389.09%. View Vitality Biopharma's Earnings History. When is Vitality Biopharma's next earnings date? Vitality Biopharma is scheduled to release their next quarterly earnings announcement on Wednesday, February 13th 2019. View Earnings Estimates for Vitality Biopharma. Has Vitality Biopharma been receiving favorable news coverage? Headlines about VBIO stock have been trending very positive this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Vitality Biopharma earned a media sentiment score of 3.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days. Who are some of Vitality Biopharma's key competitors? Some companies that are related to Vitality Biopharma include Senomyx (SNMX), Dyadic International (DYAI), BIOQUAL (BIOQ), HedgePath Pharmaceuticals (HPPI), Cleveland BioLabs (CBLI), Bioanalytical Systems (BASI), US Stem Cell (USRM), Geovax Labs (GOVX), Protalex (PRTX), ALGAE TEC LTD/S (ALGXY), Tenax Therapeutics (TENX), Eloxx Pharmaceuticals (ELOX), Intrexon (XON), National Research (NRCIB) and National Research (NRCIA). Who are Vitality Biopharma's key executives? Vitality Biopharma's management team includes the folowing people: Mr. Robert T. Brooke, CEO, Sec., Treasurer & Director (Age 39)Dr. Brandon J. Zipp Ph.D., Scientific Co-Founder and Director of R&DDr. J. Jeremiah Mann, VP of Operations & Sr. AgronomistMr. Richard McKilligan, Controller (Age 55)Dr. Dong Yuejin, Partner How do I buy shares of Vitality Biopharma? Shares of VBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Vitality Biopharma's stock price today? One share of VBIO stock can currently be purchased for approximately $0.58. How big of a company is Vitality Biopharma? Vitality Biopharma has a market capitalization of $19.84 million and generates $100,000.00 in revenue each year. Vitality Biopharma employs 7 workers across the globe. What is Vitality Biopharma's official website? The official website for Vitality Biopharma is http://www.vitality.bio. How can I contact Vitality Biopharma? Vitality Biopharma's mailing address is 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067. The company can be reached via phone at 530-231-7800 or via email at [email protected] MarketBeat Community Rating for Vitality Biopharma (OTCMKTS VBIO)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 163 (Vote Outperform)Underperform Votes: 152 (Vote Underperform)Total Votes: 315MarketBeat's community ratings are surveys of what our community members think about Vitality Biopharma and other stocks. Vote "Outperform" if you believe VBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VBIO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/22/2019 by MarketBeat.com StaffFeatured Article: What is the Quick Ratio?